CDT Equity CDT
NASDAQ CDT
$1.36 -0.09 (-6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

CDT Equity (CDT) Preferred Stock Liabilities (2022 - 2023)

Updated

CDT Equity's Preferred Stock Liabilities came in at $23.11 million for Q2 2023, down 82.9% from $135 million a year earlier but up 1.1% from the prior quarter.

Analysis

CDT Equity (CDT) Preferred Stock Liabilities (2022 - 2023) Analysis & Trends

At the end of FY2022, CDT Equity's Preferred Stock Liabilities was $136.77 million.

  • The five-year range for quarterly Preferred Stock Liabilities is $22.86 million (Q1 2023) to $136.77 million (Q4 2022).
  • Business Quant data shows CDT's Preferred Stock Liabilities at $22.86 million (Q1 2023), $136.77 million (Q4 2022) and $135.61 million (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CDT Equity 34,330.48 34,330.48 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 23.11 Mn
Mar 31, 2023 22.86 Mn
Dec 31, 2022 136.77 Mn
Sep 30, 2022 135.61 Mn
Jun 30, 2022 135.00 Mn
Mar 31, 2022 134.90 Mn
API Access

CDT Equity Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CDT&period=max&api_key=YOUR_API_KEY